# Study of PYX-106 in Solid Tumors

> **NCT05718557** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Pyxis Oncology, Inc** · enrollment: 47 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** PYX-106

## Key facts

- **NCT ID:** NCT05718557
- **Lead sponsor:** Pyxis Oncology, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-23
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2025-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05718557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05718557, "Study of PYX-106 in Solid Tumors". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT05718557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*